A randomised controlled trial of nasal decongestant to treat obstructive sleep apnoea in people with cervical spinal cord injury
Nirupama S Wijesuriya, Danny J Eckert, Amy S Jordan, Rachel Schembri, Chaminda Lewis, Hailey Meaklim, Lauren Booker, Doug Brown, Marnie Graco, David J Berlowitz
SPINAL CORD | NATURE PUBLISHING GROUP | Published : 2019
STUDY DESIGN: Prospective, double-blind, randomised, placebo-controlled, cross-over trial of nasal decongestion in tetraplegia. OBJECTIVES: Tetraplegia is complicated by severe, predominantly obstructive, sleep apnoea. First-line therapy for obstructive sleep apnoea is nasal continuous positive airway pressure, but this is poorly tolerated. High nasal resistance associated with unopposed parasympathetic activation of the upper airway contributes to poor adherence. This preliminary study tested whether reducing nasal decongestion improved sleep. SETTING: Participants' homes in Melbourne and Sydney, Australia. METHODS: Two sleep studies were performed in participants' homes separated by 1 week..View full abstract
Related Projects (1)
Awarded by National Health and Medical Research Council (NHMRC)
This research project was proudly supported by the Transport Accident Commission (Sleep Health in Quadriplegia Program) and received National Health and Medical Research Council (NHMRC) project grant funding (1065913).